Why does the "Rumor" of "Pharmaceutical Goddess" always find Grace?

Gelan, known as the "Medical Goddess", has recently encountered "rumors" again.

On September 7, Gelan, the fund manager of the China -EU Fund, spread on the Internet, applied for resignation due to unsatisfactory performance. The news attracted widespread attention in the market and quickly fermented into a hot search of the fund circle.

In response to this rumor, the China -EU Fund immediately issued a serious statement on its official website on the evening of September 7 on its official website. The statement emphasized that "today, the China -EU Fund found that there is a social account on the Internet that the false information about Gelan, the manager of the China -EU Fund, has adopted a complaint report on relevant accounts and reserved the right to further investigate its legal liability."

The reporter noticed that this is the third time Gelan has been "rumored" this year.

As early as February 10 this year, a Internet rumor pointed to Gelan, saying that there were large -scale insurance capital, financial subsidiaries, and FOF specialors, such as redeeming the amount of Gram's products, which mainly involved the direction of new energy. To this end, the China -EU Fund responded at the time that the "large redemption" of the Internet was not true news. Do not trust the rumors.

In the future, Gelan did reduce holdings of new energy standards during this period, but the amount was not as big as this rumor. Take Ningde Times as an example, Tonglian Data DataYES! Statistics show that all fund products under Gelan held a total of 26.85 million shares in Ningde Times at the end of 2021, and by the first quarter of 2022, it fell to 2.5442 million shares, a total of 140,800 shares.

Immediately after in late August, an account that claimed to be "Central Europe" posted on a social platform, "The industry logic is gone. It used to be a huge profiteering. Now that it is a dental collection, all will be collected in the future. So the logic is gone. You cannot use the previous valuation to evaluate the present. "

As a result, the news of Gelan's empty pharmaceutical stocks was quickly fermented by the network. Since then, the China -EU Fund confirmed that the account was counterfeit and had a complaint report on the relevant account.

In just half a year, Grand has encountered three rumors. Will such frequent "rumors" affect Grand's investment? And is there a certain relationship with the three rumors? In response to these issues, the reporter contacted the online customer service staff of the China -EU Fund on September 8 for consultation.

The staff member told reporters that because they have no rumors to publish the personal information of the main body for the time being, it is unclear whether the publisher of the rumored rumors is related, but "the fund manager itself will treat investment carefully

The funds of the person are configured according to their own judgment. I hope to bring more ideal returns to investors in the long run, and I hope you can not pay too much attention to short -term performance. "

As for why the Grandon will repeatedly "entrepreneurs", the above -mentioned staff said that this may be related to Gelan's popularity. "After all, she enjoys a high popularity in the industry and is familiar with everyone."

However, there are also market participants told reporters that the reason why Gram has been repeatedly "rumored" in the near future is also related to its unwilling investment performance. After some of the high -level entrance to the field, they suffered a large loss, and they often created rumors through the Internet. This is also a common thing, it is not worth a fuss. "

According to Tonglian Data DataYES! Statistics, Grand's fund industry has a period of 7.61 years, and the scale of the product is as high as 101.751 billion yuan. It is currently the largest fund manager in the management of active equity funds. Mixing A for China -Europe Medical Health A.

In Gram's 7.61 years of fund industry career, he won three awards: first, in 2016, he won the "Absolute Revenue Star Fund Award" with the excellent performance of the Chinese and flexible configuration mixed in 2016; A's shining (up to 75.23%of the income, far exceeding the average level of the same category) has achieved the "three -year open hybrid hybrid continuous winning victory of the Taurus Fund Award" and "three -year continuous return active mixed star fund award".

Gelan started the reputation of two prizes in 2019, and its product management scale rose. Linking data DataYES! Statistics show that at the end of 2019, Gelan's product management scale was only 7.135 billion yuan, which was a general level; but by the end of 2020, it leapt to 44.191 billion yuan, successfully among the "10 billion fund manager" list, and was known as "" The goddess of medicine; at the end of 2021, its management scale rose to 110.339 billion yuan, which won the title of "100 billion flow". By the second quarter of 2022, although Grand's scale decreased slightly compared with the end of last year, the scale of 101.751 billion was still the largest fund manager in the management of active equity funds.

However, when Grand's honor and product management scale increased, the level of return has formed a huge contrast with the management scale. In 2021, its cumulative income ranked 461 among the 634 fund managers of the same type. Since 2022 (August 31), its cumulative income ranks 486 among 729 types of fund managers. In other words, in the past two years, the foundation of Grandon's Kranson is basically in a significant loss.

Linking data DataYES!The fund manager scoring system shows that as of August 31, 2022, Gram's score has fallen to one star.(Economic Observation Network) Editor: Zheng Chuqiao

- END -